Valneva (NASDAQ: VALN)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-19 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.820 | -0.520 | -2.3400 | ||||
REV | 160.460M | 24.524M | -135.936M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Valneva (NASDAQ: VALN) through any online brokerage.
Other companies in Valneva’s space includes: Zentalis Pharmaceuticals (NASDAQ:ZNTL), Prothena Corp (NASDAQ:PRTA), Day One Biopharmaceutical (NASDAQ:DAWN), CareDx (NASDAQ:CDNA) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Valneva (NASDAQ: VALN) was reported by Jefferies on Tuesday, June 1, 2021. The analyst firm set a price target for 36.00 expecting VALN to rise to within 12 months (a possible 71.43% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Valneva (NASDAQ: VALN) is $21 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Valneva.
Valneva’s Q2 earnings are confirmed for Friday, August 19, 2022.
There is no upcoming split for Valneva.
Valneva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.